These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3311200)

  • 1. Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation.
    McGlave PB; Haake R; Miller W; Kim T; Kersey J; Ramsay NK
    Blood; 1987 Nov; 70(5):1325-30. PubMed ID: 3311200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
    Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y
    Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
    Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic transplantation using CD34
    Purev E; Tian X; Aue G; Pantin J; Vo P; Shalabi R; Reger RN; Cook L; Ramos C; Cho E; Worthy T; Khuu H; Stroncek D; Young NS; Childs RW
    Br J Haematol; 2017 Mar; 176(6):950-960. PubMed ID: 28169418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
    Muñoz Villa A; Ortega Aramburu JJ; Bureo Dacal E; Badell Serra I; Madero López L; Olive Oliveras T; Cubells Riero J; Maldonado Regalado MS; Ramírez Orellana M
    An Esp Pediatr; 1999 Jan; 50(1):29-32. PubMed ID: 10083639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of partially mismatched related donors extends access to allogeneic marrow transplant.
    Henslee-Downey PJ; Abhyankar SH; Parrish RS; Pati AR; Godder KT; Neglia WJ; Goon-Johnson KS; Geier SS; Lee CG; Gee AP
    Blood; 1997 May; 89(10):3864-72. PubMed ID: 9160695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
    Hill RS; Petersen FB; Storb R; Appelbaum FR; Doney K; Dahlberg S; Ramberg R; Thomas ED
    Blood; 1986 Mar; 67(3):811-6. PubMed ID: 3511988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
    Locatelli F; Bruno B; Zecca M; Van-Lint MT; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
    Blood; 2000 Sep; 96(5):1690-7. PubMed ID: 10961865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.